Find latest CLL videos · 100+ videos
A

Managing Cardiotoxicities in TKI Therapy for CLL: Atrial Fibrillation and Atrial Flutter

By Avirup Guha
81 views
October 23, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Related Videos

Penn Medicine Abramson Cancer Center

2025 Breast Cancer Highlights from International Medical Meetings: 5…

Thu, Mar 6, 2025
Total Health

2025 West Oncology Conference

Sat, Feb 8, 2025
See 1 other
17:12

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

1.7K views
21:28

Choosing BTKi or BCL2i or Combination Therapy for 1L CLL

Danielle Brander

387 views
26:06

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Kathryn Post

J. Hutchinson

668 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.8K views
05:59

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

388 views
35:12

Clinical Practice Updates in CLL/SLL

Integrity CE

M. Cortese, D. Wallace, A. Niu

364 views
15:19

Current Recommendations on Managing GI Adverse Reactions Associated …

Alberto Zambelli

955 views
22:29

1L Therapy in CLL: What Are the Best Options?

SOHO Brazil 2024

J. Burger

850 views
20:41

Managing Dermatologic Toxicities: Cutaneous irAEs Associated with Im…

Cleveland Clinic Taussig Cancer Institute

R. Unwala

278 views
20:13

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

251 views
12:18

Debates in CLL: Continuous or Finite Duration Therapy

XV Eurasian Hematology-Oncology Congress - EHOC 2024

N. Jain

215 views
14:27

Infectious Complications of Checkpoint Inhibitors: Discussing Overla…

Cleveland Clinic Taussig Cancer Institute

Z. Yetmar

219 views
21:12

3L in CLL: The Best Options in a Patient Double-Refractory to Covale…

SOHO Brazil 2024

J. Burger

505 views
15:17

Sequencing Therapies in CLL: The Importance of First-Line Treatment …

Nicole Lamanna

263 views
03:06

CLL Treatment Sequencing: The Importance of First Choice

City of Hope

S. Rosen

318 views
08:10

New

ASH 2024 Insights: Zanubrutinib, Obinutuzumab, and Venetoclax (BOVen…

2024 ASH Annual Meeting Insights Hub

J. Soumerai

110 views
25:47

Practice-Changing Updates in Indolent B-Cell Lymphomas

Massachusetts General Hospital Cancer Center

J. Soumerai

501 views
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

936 views
28:57

Systemic Therapies for Melanoma and Immune Related Adverse Effects (…

Melanoma Research Foundation

S. Chandra

42 views
14:13

Pirtobrutinib in CLL: Current and Potential Utility in the Treatment…

Nicole Lamanna

105 views
AUTOPLAY